ArticleScientific reports2025
A study of genomic complexity underlying multidrug resistance in Candida auris strains in Thailand.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Pathogenicity and virulence ofVirulence · 2026Review
- Molecular Epidemiology ofOpen forum infectious diseases · 2026Article
- Micafungin exposure drives multidrug resistance inbioRxiv : the preprint server for biology · 2026Article
- Genomic characterization of antifungal resistance patterns in Candida auris clade I: A large-scale analysis of 647 global genomes.Northern clinics of Istanbul · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Candida auris, one of the emerging multidrug-resistant Candida species, was first discovered in 2009 from the ear canal of a patient in Tokyo, Japan. Since then, several studies exhibit the possible threats of C. auris due to its versatile resistance to frontline antifungal agents. The number of studies focusing on genetic variants associated with multidrug resistance has risen over a decade. In this study, we retrieved eight C. auris strains, originated from clinical isolates in Bangkok, Thailand, and sequenced all genomes using long-read oxford nanopore technology. We have identified genome-wide single nucleotide polymorphisms (SNPs) and found that the typical genetic variation, Y132F, in ERG11 was shared between fluconazole-resistant strains, as previously reported. The fluconazole-resistant strains also exclusively harboured other nonsynonymous SNPs suggesting new mutation candidates associated with fluconazole resistance. On the caspofungin resistance aspect, shared SNPs between caspofungin-resistant strains were also found in genes associated with various biological pathways, including G32E in CDC10, a gene encoding the protein related to cell wall integrity. The other mutation was found in fungal-specific transcription factors in the Zn (II)2-Cys6 binuclear cluster, which potentially plays a central role in regulating membrane efflux pumps or cell wall production. An amino acid substitution in FKS1, a well-known protein associated with echinocandin resistance, was found in only one of two caspofungin-resistant strains at the newly discovered position, I1361T. In short, the results of our study have confirmed the typical genetic variants underpinning multidrug resistance in C. auris strains and proposed the possible new pathways involved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.